Clinical Trial Update: Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating LAM561 Acid in pediatric patients with malignant glioma and other advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-grade Glioma
• Solid Tumor

Drugs mentioned

• LAM561 Acid (LAM561 acid)

Snippet

Sponsor: Laminar Pharmaceuticals | Conditions: High-grade Glioma, Solid Tumor, Unspecified, Child | Phase 1, Phase 2 | Status: RECRUITING